Ajay S. Behl, PhD

Director of US Oncology Economics and Outcomes Research
Janssen Scientific Affairs
Titusville, NJ

Authored Items

Medication Adherence, Treatment Patterns, and Dose Reduction in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Abiraterone Acetate or Enzalutamide

Gary M. Owens, MD, Ajay S. Behl, PhD, Lorie A. Ellis, PhD, Dominic Pilon, MA, Yongling Xiao, PhD

September 2017 Vol 10, No 6 in Clinical, Original Research

Assessment of Real-World Central Nervous System Events in Patients with Advanced Prostate Cancer Using Abiraterone Acetate, Bicalutamide, Enzalutamide, or Chemotherapy

Dominic Pilon, MA, Brian Caveney, MD, JD, MPH, Ajay S. Behl, PhD, Lorie A. Ellis, PhD, Marie-Noëlle Robitaille, MA, Patrick Lefebvre, MA, Nancy A. Dawson, MD

May 2017 Vol 10, No 3 in Clinical

Last modified: September 22, 2017

• 
• 
• 

• 
• 
• 

•